CRISPR Therapeutics (NASDAQ: CRSP)
CRISPR Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
CRISPR Therapeutics Company Info
CRISPR Therapeutics is a biotech company using gene therapy to try to correct genetic mutations to treat and cure diseases.
News & Analysis
Thinking of Buying CRISPR Therapeutics Stock? Watch These 2 Key Numbers
It won't be able to be profitable without hitting its targets for both of these figures.
The Best CRISPR Companies to Invest In
These CRISPR stocks could be big winners for patient investors.
Top Biotech ETFs to Buy Now
Here are the five best biotech ETFs to invest in right now.
The Ultimate Biotech Stock to Buy With $50 Right Now
This company might be worth far more than many realize.
Investing in Life Sciences Stocks
Is CRISPR Therapeutics Stock a Buy?
The markets this biotech is looking to enter could be extremely lucrative.
2 Biotech Stocks That Are Screaming Buys This Month
They won't remain southbound forever.
This Healthcare Growth Stock Could Be a Steal of a Deal Right Now
CRISPR Therapeutics is trading around multiyear lows.
Valuation
Podcast Episodes
"The Era of the Gene-Edited Human Is Here"
An investor's look.
Breaking Down CRISPR Technology
What investors need to know.
Is Amarin's Fish Oil Pill on Track to Become a Blockbuster?
Plus, how gene-editing company CRISPR Therapeutics just took a big step forward.
Did China’s “Designer Babies” Just Open Pandora’s Box?
What will this mean for healthcare and for the future of society?
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.